BRK.B vs OGN · rev $371.44B vs P/E 3.4, rev $3.02B
BRK.B (BRK.B) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
BRK.B (BRK.B) common stock. It is led by Warren Buffett.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported BRK.B revenue for 2025-12-31 was $371.44B. Net income was $66.97B. Revenue was up 616.8% from 2015-12-31 to 2025-12-31. BRK.B currently screens at market cap $0.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
BRK.B currently screens at market cap $0. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the BRK.B and OGN stock pages for the full models.
Not investment advice.